91
Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy
Condition(s):Hypertrophic CardiomyopathyLast Updated:November 28, 2022Completed
Valsartan: 509 Clinical Trials, Page 10 of 51
Hide Studies Not Open or Pending
92
Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
Condition(s):Pediatric Hypertension With or Without CKDLast Updated:September 27, 2017Completed
93
Influence of Sacubitril/Valsartan on Autonomic Cardiac Nervous System in Heart Failure Patients: an Exploratory Study
Condition(s):Heart Failure PatientsLast Updated:June 21, 2022Completed
94
To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers
Condition(s):HealthyLast Updated:June 22, 2007Completed
95
Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)
Condition(s):Hypertension; ObesityLast Updated:June 3, 2010Unknown status
96
Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study
Condition(s):Stage D Heart FailureLast Updated:June 7, 2021Recruiting
97
Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide
Condition(s):Healthy Normotensive ParticipantsLast Updated:January 15, 2013Completed
98
24 Hour Ambulatory Cardiac Oxygen Consumption
Condition(s):HypertensionLast Updated:December 27, 2021Completed
99
Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction
Condition(s):Heart FailureLast Updated:December 23, 2021Enrolling by invitation
100
Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose
Condition(s):HypertensionLast Updated:January 5, 2009Completed